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Abstract
Introduction: Budd-Chiari syndrome is a very rare pathological entity that ultimately leads to liver failure. Several
therapeutic modalities, including percutaneous transluminal angioplasty, have been attempted to save the life of
patients with Budd-Chiari syndrome. Few reports have described a salvage living donor liver transplantation
performed after percutaneous transluminal angioplasty in a patient with acute Budd-Chiari syndrome.
Case presentation: A 26-year-old Japanese man developed severe progressive manifestations, such as massive
ascites and hematemesis due to rupture of esophageal varices. After making several investigations, we diagnosed
the case as Budd-Chiari syndrome. We first performed percutaneous transluminal angioplasty to dilate a short-
segment stenosis of his inferior vena cava. The first percutaneous transluminal angioplasty greatly improved the
clinical manifestations. However, after a year, re-stenosis was detected, and a second percutaneous transluminal
angioplasty failed to open the severe stricture of his inferior vena cava. Since our patient had manifestations of
acute liver failure, we decided to perform salvage living donor liver transplantation from his brother. The
transplantation was successfully performed and all clinical manifestations were remarkably alleviated.
Conclusion: In cases of recurrent Budd-Chiari syndrome, the blocked hepatic venous outflow is not always
relieved, even with invasive therapies. We have to take into account the possibility of adopting alternative salvage
therapies if the first therapeutic modalities fail. When invasive therapy such as percutaneous transluminal
angioplasty fails, liver transplantation should be considered as an alternative option.
Introduction
Budd-Chiari syndrome (BCS) is a rare clinical condition
that results from obstruction of the hepatic venous out-
flow and has a predisposition to thrombosis of the
major hepatic veins and/or inferior vena cava (IVC) at
points proximal to the right atrium [1]. The manifesta-
tions of BCS are variable, such as hepatic enlargement,
pain, tenderness, and portal hypertension [2]. When the
occlusion is rapid, the patient may present with acute
portal hypertensive manifestations, such as progressive
massive painful refractory ascites and rupture of
esophageal varices. This clinical situation is called acute
BCS, and several therapeutic options, including medical
treatments (for example, anticoagulants and diuretics)
and invasive management, have been employed [2]. Sev-
eral invasive therapeutic modalities for BCS have been
reported, such as percutaneous transluminal angioplasty
(PTA), transjugular intrahepatic portosystemic shunt
(TIPS), and orthotopic liver transplantation [3]. For
acute BCS, these invasive therapeutic options are likely
to be the most appropriate modalities [3]. Even with
these invasive therapies, however, recovery of the
obstructed hepatic venous outflow is not always
achieved. In that case, sequential salvage therapeutic
modalities should be considered since acute BCS
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failure. We report the case of a patient with recurrent
BCS in whom the first PTA was successful, but the sec-
ond PTA failed to re-open the stenosis of the IVC.
Since our patient showed manifestations of acute liver
failure, we decided to perform salvage living donor liver
transplantation (LDLT) from his brother. The transplan-
tation was successful, and all clinical manifestations
were remarkably alleviated.
Case presentation
A Japanese 26-year-old man without any relevant medi-
cal history had progressive refractory massive ascites of
unknown origin. He shortly developed hematemesis. An
endoscopy revealed spurting bleeding from esophageal
varices, and he was referred to and then admitted into
our hospital. He underwent emergency endoscopic
injection sclerotherapy (EIS). The laboratory data on
admission showed severe liver dysfunction without any
suggestion of chronic liver diseases, such as cirrhosis.
The hepatitis viral markers, including hepatitis B and C,
were all negative. Color Doppler ultrasonography (US)
revealed a heterogeneous enlarged liver, shunt vessels
between his middle and right hepatic veins (MHV and
RHV, respectively), and retrograde flow in MHV. Com-
puted tomography (CT) is a more sensitive modality for
showing parenchymal abnormalities. In our case,
enhanced CT revealed much clearer heterogeneity of
the liver with decreased attenuation in the periphery. It
also showed shunt vessels between MHV and RHV. The
latter was markedly dilated, and it seemed to have some
flow into the IVC, whereas his left hepatic vein was
obstructed. Furthermore, sagittal CT images suggested
severe stricture of his IVC at the level of the liver.
Angiograms confirmed marked narrowing of his IVC at
t h el e v e lo ft h el i v e r( F i g u r e1 A ) .M a g n e t i cr e s o n a n c e
imaging (MRI) revealed findings similar to those of the
CT. From these findings, and the rapid onset of the clin-
ical manifestations, we diagnosed this patient as having
acute BCS. Within one week, our patient developed
massive hematemesis again. Subsequently, he showed
manifestations of acute liver failure, possibly due to
“shock liver”. Since we could not find a donor for
deceased liver donor transplantation (DLDT), we
decided to perform PTA first. A balloon catheter was
inserted into his right femoral vein, and the stricture of
the IVC at the level of his liver was dilated using a 12 ×
40 mm balloon catheter. After PTA, the pressure differ-
ence between his IVC and his right atrium decreased
from 250 mmH2O to 50 mmH2O, and color Doppler
US showed that the blood flow in his MHV had recov-
ered to the normal antegrade flow. His clinical manifes-
tations, such as ascites, dramatically improved, and his
liver function also gradually recovered with time. About
one month after the PTA, an enhanced 3 D CT exami-
nation revealed that the heterogeneity of the liver, the
IVC stricture at the level of the liver, and the liver dys-
function had markedly improved. The endoscopic find-
ings of the varices were also alleviated. Our patient was
discharged, and regular follow-up was performed.
After one year, color Doppler US showed that the
hepatic venous outflow had deteriorated again, despite
our patient being given an anticoagulant after the initial
PTA. Sagittal CT images again showed severe stricture
of his IVC at the level of the hepatic veins. Our patient
then developed massive hematemesis again due to a
rupture of the varices. We performed emergency EIS, to
control the bleeding. Although we performed PTA
again, balloon dilatation was not effective this time.
Doppler US showed that his RHV and MHV were com-
pletely occluded with regurgitation in his MHV, and
thick shunt vessels from his MHV to RHV were noticed
(Figure 2). His clinical condition deteriorated over sev-
eral weeks, including the development of severe hepatic
failure. This time, our patient’s brother volunteered to
become a donor for LDLT. After the physician and sur-
geon obtained written informed consent from the
donor, LDLT was performed using the left lobe of the
brother’s liver. Macroscopically, the recipient liver was
swollen and reddish, indicating severe secondary conges-
tion (Figure 3A). Microscopic examination showed evi-
dence of impaired blood outflow, including congestion,
coagulative necrosis, and loss of hepatocytes without
severe inflammatory infiltrates associated with fibrosis
development (Figure 3B). After the operation, our
patient’s general condition improved and his manifesta-
tions were dramatically alleviated. One year after the
LDLT, our patient was discharged with his liver func-
tioning well. The laboratory data indicated a healthy
Figure 1 Angiograms of the IVC before and after PTA. The IVC
showed marked narrowing before PTA (A: black arrow). A balloon
catheter was inserted into the right femoral vein, and the stricture
of the IVC at the level of the liver was dilated using a 12 × 40 mm
balloon catheter. After the first PTA, the stenosis was significantly
improved (B: white arrow).
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(Table 1). Moreover, multi-slice CT imaging showed
that the congestion of the liver had completely disap-
peared with normal flow inside the vessels (Figure 4).
Discussion
BCS is a clinical condition characterized by hepatic
venous outflow obstruction due to various underlying
causes [1]. BCS is uncommon, with an incidence rate of
about one in two and a half million people per year, and
current knowledge about its etiology is still insufficient
[2]. Most western cases of BCS have a known etiology
such as protein-C or -S deficiency, and myeloprolifera-
tive diseases, whereas most Japanese cases are idiopathic
including acute BCS [4]. The Japanese Ministry of
Health and Welfare Research Committee on Aberrant
Portal Blood Flow carried out an epidemiological survey
and clinical study on BCS, and reported that the
majority of BCS patients in Japan are idiopathic, with an
obstructing lesion in the IVC [5]. This was also the case
in our patient. It has been reported that stenosis of the
IVC at the level of the liver is a common cause of non-
cirrhotic ascites, which develop within a short period in
developing countries [6]. These patients generally have a
poor nutritional status, which is now recognized as one
of the causes of an immune-compromised state. Patients
with such status frequently have thrombophlebitis of the
IVC at the level of the liver, which probably results in
stenosis or thrombosis of the IVC. Before the onset of
symptoms, our patient suffered from alcohol abuse and
did not have sufficient nutrition. It may be possible that
he had a similar situation of malnutrition, which led to
temporary acute stenosis of the IVC.
Clinically, in most cases of BCS, leg edema, abdominal
fullness, and subcutaneous venous dilatation over the
trunk gradually appear. In some cases, severe clinical
manifestations such as progressive refractory ascites and
rupture of esophageal varices occur within a short per-
iod; a condition classified as acute BCS [7]. Acute BCS
often results in fulminant liver failure due to severe liver
congestion. In our case, the clinical manifestations
developed within a short period accompanied with
severe liver dysfunction, which could be classified as
acute BCS. Although the general prognosis of acute BCS
is poor, the outcome may be fair with accurate early
diagnosis and effective treatment. We were able to make
an early diagnosis of acute BCS and identify the stricture
Figure 3 Photomicrographs of the recipient liver at the time of
living donor liver transplantation. (A) Macroscopically, the
recipient liver was swollen and reddish, indicating severe secondary
congestion. (B) Microscopically, there was evidence of impaired
blood outflow, including congestion, coagulative necrosis, and loss
of hepatocytes without the severe inflammatory infiltrates
associated with fibrosis development. Original magnification is ×40.
Table 1 Laboratory data of the patient
Before PTA Before surgery After surgery
Bilirubin (mg/dL) 1.8 10.6 1.0
Albumin (g/dL) 2.5 2.0 3.3
PT-INR 0.99 1.86 0.74
Creatinine (mg/dL) 0.7 1.3 1.0
MELD Score 9 25 6
Child-Pugh Score 8 14 N/A
Figure 4 Multi-slice CT imaging one year after the
transplantation. The sagittal (A) and enhanced images (B) show
that the congestion of the liver completely disappeared with
normal flow inside the vessels.
Figure 2 Images showing various features of re-stenosis after
the first PTA. One year after the first PTA, angiograms of the IVC
showed severe stricture of the IVC at the level of the hepatic veins
(A: black arrow). Doppler US showed that the RHV and MHV were
completely occluded with regurgitation in MHV, and thick shunt
vessels from MHV to RHV were noticed (B: white arrow).
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nostic modalities, such as Doppler US, 3-D CT, and
MRI. After the accurate diagnosis, optimized therapy
should be employed for acute BCS. As in our case,
about one third of patients harbor short-segment steno-
sis of either the hepatic veins or IVC. Since such
patients are candidates for PTA [2], we first performed
PTA and achieved good clinical results for one year.
However, it has been reported that PTA has a high level
of recurrence and sometimes needs to be repeated.
About half the patients who underwent PTA developed
re-stenosis within one year. Likewise, our patient had
re-stenosis approximately one year after the first PTA
[8]. Esophageal varices and ascites developed very
quickly along with re-stenosis. We attempted PTA
again, but the second time was not effective. The IVC
was temporarily dilated but soon re-stenosed. It was
reported that an expandable metallic stent (EMS) can be
useful for overcoming and reducing the occurrence of
re-stenosis or obstructions after PTA [2]. However, in
our case, the stenosis level of the IVC and debouch of
the hepatic veins were very close. The radiologist in our
hospital concluded that we could not employ EMS in
this case since sufficient long-term blood flow could not
be guaranteed.
Liver transplantation has been used as an alternative
to, or after failure of, surgical interventions for BCS [9].
It has been proposed that patients with fulminant hepa-
tic failure consequent to BCS should be listed with the
United Network for Organ Sharing system status 1A
[10]. However, in Japan, it is extremely difficult to wait
for DLDT due to the severe shortage of the number of
donors. Although the surgical techniques of LDLT are
different from those of DLDT, refined techniques were
developed in Japan thanks to the enormous efforts of
Japanese surgeons [9]. Although patients with BCS
account for only 1-2% of all orthotopic liver transplants,
fortunately the department of surgery in our hospital
has experience with LDLT. Since our patient’sb r o t h e r
suggested becoming a donor for LDLT, we could per-
form LDLT in the current case. As our patient suffered
acute liver failure, all other therapies were less likely to
be successful. LDLT was successfully performed, and all
the patient’s clinical manifestations were significantly
alleviated. Therefore, liver transplantation should be
considered as one of the alternative options for thera-
peutic salvage.
Conclusion
We described the case of a patient with recurrent BCS
in whom the first PTA was successful, but the second
PTA failed to re-open the stenosis of the IVC. We per-
formed salvage LDLT from his brother. The transplanta-
tion was successfully performed, and all clinical
manifestations were significantly alleviated. In cases of
recurrent BCS, the blocked hepatic venous outflow is
not always relieved, even with invasive therapies. We
have to consider the possibility of adopting alternative
salvage therapies if the first therapeutic modalities fail.
When invasive therapeutic modalities such as PTA fail,
liver transplantation should be considered as an alterna-
tive option.
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